BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19671824)

  • 1. Resolution of osteonecrosis of the jaw after teriparatide [recombinant human PTH-(1-34)] therapy.
    Lau AN; Adachi JD
    J Rheumatol; 2009 Aug; 36(8):1835-7. PubMed ID: 19671824
    [No Abstract]   [Full Text] [Related]  

  • 2. More on the resolution of bisphosphonate-associated osteonecrosis of the jaw.
    Tsai KY; Huang CS; Huang GM; Yu CT
    J Rheumatol; 2010 Mar; 37(3):675; author reply 676. PubMed ID: 20197569
    [No Abstract]   [Full Text] [Related]  

  • 3. Multiple osteonecrosis of the jaw, oral bisphosphonate therapy and refractory rheumatoid arthritis (Pathological fracture associated with ONJ and BP use for osteoporosis).
    Grana J; Mahia IV; Meizoso MO; Vazquez T
    Clin Exp Rheumatol; 2008; 26(2):384-5. PubMed ID: 18565271
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diphosphonate therapy and osteonecrosis of the jaw].
    Løkken P; Skoglund LA; Skjelbred P
    Tidsskr Nor Laegeforen; 2007 Aug; 127(15):1945-7. PubMed ID: 17700737
    [No Abstract]   [Full Text] [Related]  

  • 5. Tetracycline-guided debridement and cone beam computed tomography for the treatment of bisphosphonate-related osteonecrosis of the jaw: a technical note.
    Fleisher KE; Doty S; Kottal S; Phelan J; Norman RG; Glickman RS
    J Oral Maxillofac Surg; 2008 Dec; 66(12):2646-53. PubMed ID: 19022151
    [No Abstract]   [Full Text] [Related]  

  • 6. Teriparatide therapy for alendronate-associated osteonecrosis of the jaw.
    Cheung A; Seeman E
    N Engl J Med; 2010 Dec; 363(25):2473-4. PubMed ID: 20950167
    [No Abstract]   [Full Text] [Related]  

  • 7. Bisphosphonate-related osteonecrosis of the jaw and left thumb.
    Longo R; Castellana MA; Gasparini G
    J Clin Oncol; 2009 Dec; 27(35):e242-3. PubMed ID: 19858386
    [No Abstract]   [Full Text] [Related]  

  • 8. Bisphosphonate-induced osteonecrosis of the jaw.
    Sharma V; Nagaraj S; Choksey U; Hegde A; Samant R; Balakrishnan C
    J Assoc Physicians India; 2011 Aug; 59():516-7. PubMed ID: 21887911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral bisphosphonates and osteonecrosis of the jaw: are the MHRA recommendations appropriate?
    Compston J
    Menopause Int; 2007 Jun; 13(2):54-5. PubMed ID: 17540133
    [No Abstract]   [Full Text] [Related]  

  • 10. Biophosphonate-related osteonecrosis of the jaws.
    Ruggiero SL; Woo SB
    Dent Clin North Am; 2008 Jan; 52(1):111-28, ix. PubMed ID: 18154867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral bisphosphonates.
    Zahrowski JJ
    J Am Dent Assoc; 2009 May; 140(5):517-8; author reply 518-9. PubMed ID: 19411514
    [No Abstract]   [Full Text] [Related]  

  • 12. Teriparatide therapy for denosumab-induced osteonecrosis of the jaw in a male osteoporotic patient.
    Neuprez A; Rompen E; Crielaard JM; Reginster JY
    Calcif Tissue Int; 2014 Jul; 95(1):94-6. PubMed ID: 24804929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diphosphonates can cause necrosis of the jaw. Patients with malignant skeletal diseases are at risk].
    Jarnbring F; Ulmner M; Blomlöf J; Ljungman P
    Lakartidningen; 2006 May 31-Jun 6; 103(21-22):1741-3. PubMed ID: 16826719
    [No Abstract]   [Full Text] [Related]  

  • 14. Osteonecrosis of the jaw after osteoporosis therapy with denosumab following long-term bisphosphonate therapy.
    Rachner TD; Platzbecker U; Felsenberg D; Hofbauer LC
    Mayo Clin Proc; 2013 Apr; 88(4):418-9. PubMed ID: 23541016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonates: a potential threat to your patients.
    Dreiman BB
    J Indiana Dent Assoc; 2005-2006 Winter; 84(4):4-9. PubMed ID: 16605211
    [No Abstract]   [Full Text] [Related]  

  • 16. Teriparatide therapy for osteonecrosis of the jaw.
    Chtioui H; Lamine F; Daghfous R
    N Engl J Med; 2011 Mar; 364(11):1081-2; author reply 1082. PubMed ID: 21410382
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bisphosphonate-associated osteonecrosis of the jaws. 3. Two case reports].
    Schortinghuis J; Meijndert L; de Visscher JG; Witjes MJ
    Ned Tijdschr Tandheelkd; 2007 Oct; 114(10):432-5. PubMed ID: 17972612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonate related osteonecrosis of the palate: report of a case managed with free tissue transfer.
    Engroff SL; Coletti D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 May; 105(5):580-2. PubMed ID: 18442742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orofacial pain - a presenting symptom of bisphosphonate associated osteonecrosis of the jaws.
    Srinivasan D; Shetty S; Ashworth D; Grew N; Millar B
    Br Dent J; 2007 Jul; 203(2):91-2. PubMed ID: 17660779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Teriparatide for bone loss in the jaw.
    Grey A
    N Engl J Med; 2010 Dec; 363(25):2458-9. PubMed ID: 20950165
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.